Susquehanna International Group, LLP Inventiva S.A. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Inventiva S.A. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 16,327 shares of IVA stock, worth $37,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,327Holding current value
$37,552% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IVA
# of Institutions
8Shares Held
4.85MCall Options Held
0Put Options Held
0-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$6.08 Million0.25% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$3.36 Million0.21% of portfolio
-
Bvf Inc San Francisco, CA686KShares$1.58 Million0.04% of portfolio
-
Commonwealth Equity Services, LLC39.7KShares$91,3900.0% of portfolio
-
Morgan Stanley New York, NY1.4KShares$3,2190.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $96.9M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...